{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T03:48:35Z","timestamp":1783655315238,"version":"3.55.0"},"reference-count":75,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,3,11]],"date-time":"2021-03-11T00:00:00Z","timestamp":1615420800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.biopha.2021.111494","type":"journal-article","created":{"date-parts":[[2021,5,8]],"date-time":"2021-05-08T13:07:06Z","timestamp":1620479226000},"page":"111494","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"special_numbering":"C","title":["Therapeutic advancement of simvastatin-loaded solid lipid nanoparticles (SV-SLNs) in treatment of hyperlipidemia and attenuating hepatotoxicity, myopathy and apoptosis: Comprehensive study"],"prefix":"10.1016","volume":"139","author":[{"given":"Hagar B.","family":"Abo-zalam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ezzeldein S.","family":"El-Denshary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rania M.","family":"Abdelsalam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Islam A.","family":"Khalil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud M.","family":"Khattab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed A.","family":"Hamzawy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2021.111494_bib1","first-page":"6055","article-title":"Natural product-based nanomedicine: recent advances and issues","volume":"10","author":"Watkins","year":"2015","journal-title":"Int. J. Nanomed."},{"issue":"1\u20132","key":"10.1016\/j.biopha.2021.111494_bib2","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.ejps.2012.10.022","article-title":"Development of solid lipid nanoparticles (SLNs) of lopinavir using hot self nano-emulsification (SNE) technique","volume":"48","author":"Negi","year":"2013","journal-title":"Eur. J. Pharm. Sci."},{"issue":"2","key":"10.1016\/j.biopha.2021.111494_bib3","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1161\/01.CIR.101.2.207","article-title":"Current perspectives on statins","volume":"101","author":"Maron","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.biopha.2021.111494_bib4","doi-asserted-by":"crossref","first-page":"213","DOI":"10.2147\/CLEP.S78145","article-title":"Statin prescription patterns, adherence, and attainment of cholesterol treatment goals in routine clinical care: a Danish population-based study","volume":"7","author":"Svensson","year":"2015","journal-title":"Clin. Epidemiol."},{"issue":"12","key":"10.1016\/j.biopha.2021.111494_bib5","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1080\/14740338.2016.1238068","article-title":"Severity of statin-induced adverse effects on muscle and associated conditions: data from the DAMA study","volume":"15","author":"Pedro-Botet","year":"2016","journal-title":"Expert Opin. Drug Saf."},{"issue":"2","key":"10.1016\/j.biopha.2021.111494_bib6","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1002\/hep.27157","article-title":"Spectrum of statin hepatotoxicity: experience of the drug\u2010induced liver injury network","volume":"60","author":"Russo","year":"2014","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.biopha.2021.111494_bib7","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1007\/s00125-015-3528-5","article-title":"Increased risk of diabetes with statin treatment is associated with impaired insulin sensitivity and insulin secretion: a 6 year follow-up study of the METSIM cohort","volume":"58","author":"Cederberg","year":"2015","journal-title":"Diabetologia"},{"issue":"1","key":"10.1016\/j.biopha.2021.111494_bib8","doi-asserted-by":"crossref","first-page":"22","DOI":"10.3390\/jcm9010022","article-title":"Statin-related myotoxicity: a comprehensive review of pharmacokinetic, pharmacogenomic and muscle components","volume":"9","author":"Turner","year":"2020","journal-title":"J. Clin. Med."},{"issue":"7","key":"10.1016\/j.biopha.2021.111494_bib9","doi-asserted-by":"crossref","first-page":"526","DOI":"10.7326\/0003-4819-158-7-201304020-00004","article-title":"Discontinuation of statins in routine care settings: a cohort study","volume":"158","author":"Zhang","year":"2013","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.biopha.2021.111494_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12872-020-01482-5","article-title":"Time trends analysis of statin prescription prevalence, therapy initiation, dose intensity, and utilization from the hospital information system of Jinshan Hospital, Shanghai (2012\u20132018)","volume":"20","author":"Liu","year":"2020","journal-title":"BMC Cardiovasc. Disord."},{"issue":"1\u20132","key":"10.1016\/j.biopha.2021.111494_bib11","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.ijpharm.2011.05.044","article-title":"Nanostructured lipid carrier versus solid lipid nanoparticles of simvastatin: comparative analysis of characteristics, pharmacokinetics and tissue uptake","volume":"415","author":"Tiwari","year":"2011","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.biopha.2021.111494_bib12","series-title":"Guide for the Care and Use of Laboratory Animals","author":"N.R. Council","year":"2010"},{"issue":"12","key":"10.1016\/j.biopha.2021.111494_bib13","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1111\/j.1440-1681.1997.tb02724.x","article-title":"Rapid reversal of endothelial dysfunction in hypercholesterolaemic rabbits treated with simvastatin and pravastatin","volume":"24","author":"Jorge","year":"1997","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"issue":"1","key":"10.1016\/j.biopha.2021.111494_bib14","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.ejps.2012.05.010","article-title":"Are nanostructured lipid carriers (NLCs) better than solid lipid nanoparticles (SLNs): development, characterizations and comparative evaluations of clotrimazole-loaded SLNs and NLCs?","volume":"47","author":"Das","year":"2012","journal-title":"Eur. J. Pharm. Sci."},{"issue":"2","key":"10.1016\/j.biopha.2021.111494_bib15","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1208\/s12249-010-9414-z","article-title":"Development and statistical optimization of solid lipid nanoparticles of simvastatin by using 2 3 full-factorial design","volume":"11","author":"Shah","year":"2010","journal-title":"Aaps Pharmscitech"},{"issue":"1","key":"10.1016\/j.biopha.2021.111494_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/08982104.2015.1137313","article-title":"Augmented simvastatin cytotoxicity using optimized lipid nanocapsules: a potential for breast cancer treatment","volume":"27","author":"Safwat","year":"2017","journal-title":"J. Liposome Res."},{"issue":"3","key":"10.1016\/j.biopha.2021.111494_bib17","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.nano.2015.01.004","article-title":"Design and optimization of oleanolic\/ursolic acid-loaded nanoplatforms for ocular anti-inflammatory applications","volume":"11","author":"Alvarado","year":"2015","journal-title":"Nanomed.: Nanotechnol. Biol. Med."},{"key":"10.1016\/j.biopha.2021.111494_bib18","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.ijbiomac.2016.10.012","article-title":"Multilayer micro-dispersing system as oral carriers for co-delivery of doxorubicin hydrochloride and P-gp inhibitor","volume":"94","author":"Feng","year":"2017","journal-title":"Int. J. Biol. Macromol."},{"issue":"3","key":"10.1016\/j.biopha.2021.111494_bib19","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.ijbiomac.2010.10.005","article-title":"Synthesis and in vitro evaluation of carboxymethyl starch\u2013chitosan nanoparticles as drug delivery system to the colon","volume":"48","author":"Saboktakin","year":"2011","journal-title":"Int. J. Biol. Macromol."},{"issue":"4","key":"10.1016\/j.biopha.2021.111494_bib20","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1080\/02652048.2016.1178351","article-title":"Formulation of venlafaxine for once daily administration using polymeric material hybrids","volume":"33","author":"Ibrahim","year":"2016","journal-title":"J. Microencapsul."},{"issue":"3","key":"10.1016\/j.biopha.2021.111494_bib21","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1208\/s12248-010-9185-1","article-title":"DDSolver: an add-in program for modeling and comparison of drug dissolution profiles","volume":"12","author":"Zhang","year":"2010","journal-title":"AAPS J."},{"issue":"2","key":"10.1016\/j.biopha.2021.111494_bib22","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0928-0987(01)00095-1","article-title":"Modeling and comparison of dissolution profiles","volume":"13","author":"Costa","year":"2001","journal-title":"Eur. J. Pharm. Sci."},{"issue":"4","key":"10.1016\/j.biopha.2021.111494_bib23","article-title":"Plasma lipid profile of Wistar albino rats fed palm oil-supplemented diets","volume":"4","author":"Onyeali","year":"2010","journal-title":"Int. J. Biol. Chem. Sci."},{"issue":"2","key":"10.1016\/j.biopha.2021.111494_bib24","article-title":"High fatty diet effects on rat liver","volume":"11","author":"Kara\u00e7or","year":"2014","journal-title":"Eur. J. Gen. Med."},{"issue":"5","key":"10.1016\/j.biopha.2021.111494_bib25","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/jps.2600720503","article-title":"Methods for vascular access and collection of body fluids from the laboratory rat","volume":"72","author":"Cocchetto","year":"1983","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.biopha.2021.111494_bib26","unstructured":"R.A.B. Drury, E. Wallington, Carleton's histological technique, 1967."},{"key":"10.1016\/j.biopha.2021.111494_bib27","series-title":"Theory and Practice of Histological Techniques","author":"Bancroft","year":"2008"},{"key":"10.1016\/j.biopha.2021.111494_bib28","series-title":"Guide Book: Immunohistochemical Staining Methods","author":"Rudbeck","year":"2013"},{"issue":"11","key":"10.1016\/j.biopha.2021.111494_bib29","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.4236\/pp.2014.511115","article-title":"Simvastatin potentiates the antihyperglycemic, antidyslipidimic and antioxidative effect of glibenclamide on alloxan-induced diabetic rats","volume":"5","author":"Begum","year":"2014","journal-title":"Pharmacol. Pharm."},{"key":"10.1016\/j.biopha.2021.111494_bib30","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jddst.2016.03.009","article-title":"A novel cationic nanostructured lipid carrier for improvement of ocular bioavailability: design, optimization, in vitro and in vivo evaluation","volume":"33","author":"Liu","year":"2016","journal-title":"J. Drug Deliv. Sci. Technol."},{"issue":"1","key":"10.1016\/j.biopha.2021.111494_bib31","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1080\/10717544.2016.1247924","article-title":"Antitumor activity of intratracheal inhalation of temozolomide (TMZ) loaded into gold nanoparticles and\/or liposomes against urethane-induced lung cancer in BALB\/c mice","volume":"24","author":"Hamzawy","year":"2017","journal-title":"Drug Deliv."},{"issue":"1\u20132","key":"10.1016\/j.biopha.2021.111494_bib32","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.ijpharm.2008.07.017","article-title":"A controlled-release ocular delivery system for ibuprofen based on nanostructured lipid carriers","volume":"363","author":"Li","year":"2008","journal-title":"Int. J. Pharm."},{"issue":"5","key":"10.1016\/j.biopha.2021.111494_bib33","doi-asserted-by":"crossref","first-page":"526","DOI":"10.3109\/03639045.2010.527983","article-title":"Oral solid compritol 888 ATO nanosuspension of simvastatin: optimization and biodistribution studies","volume":"37","author":"Shah","year":"2011","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.biopha.2021.111494_bib34","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ejps.2016.09.004","article-title":"Simvastatin-loaded nanostructured lipid carriers attenuate the atherogenic risk of erythrocytes in hyperlipidemic rats","volume":"96","author":"Harisa","year":"2017","journal-title":"Eur. J. Pharm. Sci."},{"issue":"1\u20132","key":"10.1016\/j.biopha.2021.111494_bib35","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.ijpharm.2010.01.018","article-title":"Preparation, characterization, and anticancer effects of simvastatin\u2013tocotrienol lipid nanoparticles","volume":"389","author":"Ali","year":"2010","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.biopha.2021.111494_bib36","doi-asserted-by":"crossref","unstructured":"A.J. Shinde, H.N. More, Pharmacokinetics and enhanced oral bioavailability in albino rabbits of simvastatin nanoparticles, 2014.","DOI":"10.22270\/jddt.v4i3-s.866"},{"issue":"5","key":"10.1016\/j.biopha.2021.111494_bib37","first-page":"591","article-title":"Simvastatin solid lipid nanoparticles for oral delivery: formulation development and in vivo evaluation","volume":"75","author":"Padhye","year":"2013","journal-title":"Indian J. Pharm. Sci."},{"issue":"1","key":"10.1016\/j.biopha.2021.111494_bib38","first-page":"98","article-title":"Effects of ethanolic extract of green tea on decreasing the level of lipid profile in rat","volume":"3","author":"Amanolahi","year":"2013","journal-title":"Avicenna J. Phytomed."},{"key":"10.1016\/j.biopha.2021.111494_bib39","doi-asserted-by":"crossref","DOI":"10.1124\/mol.108.053678","article-title":"Statin-induced liver injury involves cross-talk between cholesterol and selenoprotein biosynthetic pathways","author":"Kromer","year":"2009","journal-title":"Mol. Pharmacol."},{"issue":"11","key":"10.1016\/j.biopha.2021.111494_bib40","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1002\/ptr.2146","article-title":"Ameliorative effects of pycnogenol\u00ae on carbon tetrachloride\u2010induced hepatic oxidative damage in rats","volume":"21","author":"Ahn","year":"2007","journal-title":"Phytother. Res."},{"issue":"2","key":"10.1016\/j.biopha.2021.111494_bib41","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.molmet.2016.12.001","article-title":"JNK at the crossroad of obesity, insulin resistance, and cell stress response","volume":"6","author":"Solinas","year":"2017","journal-title":"Mol. Metab."},{"issue":"42","key":"10.1016\/j.biopha.2021.111494_bib42","doi-asserted-by":"crossref","first-page":"21848","DOI":"10.1074\/jbc.C116.732990","article-title":"Metformin improves metabolic memory in high fat diet (HFD)-induced renal dysfunction","volume":"291","author":"Tikoo","year":"2016","journal-title":"J. Biol. Chem."},{"issue":"1 Suppl.","key":"10.1016\/j.biopha.2021.111494_bib43","article-title":"Lipid stimulates myoglobin expression in skeletal muscle cells","volume":"26","author":"Schlater","year":"2012","journal-title":"FASEB J."},{"issue":"3","key":"10.1016\/j.biopha.2021.111494_bib44","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.jep.2009.09.003","article-title":"The effect of total extract of Securigera securidaca L. seeds on serum lipid profiles, antioxidant status, and vascular function in hypercholesterolemic rats","volume":"126","author":"Garjani","year":"2009","journal-title":"J. Ethnopharmacol."},{"issue":"1","key":"10.1016\/j.biopha.2021.111494_bib45","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1128\/MCB.24.1.36-45.2004","article-title":"Transcription factor Nrf2 regulates inflammation by mediating the effect of 15-deoxy-\u039412, 14-prostaglandin J2","volume":"24","author":"Itoh","year":"2004","journal-title":"Mol. Cell. Biol."},{"issue":"10","key":"10.1016\/j.biopha.2021.111494_bib46","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1093\/jn\/138.10.1866","article-title":"Increased apoptosis in high-fat diet\u2013induced nonalcoholic steatohepatitis in rats is associated with c-Jun NH2-terminal kinase activation and elevated proapoptotic Bax","volume":"138","author":"Wang","year":"2008","journal-title":"J. Nutr."},{"key":"10.1016\/j.biopha.2021.111494_bib47","first-page":"140","article-title":"The effect of Crataegus (Hawthorn) extract alone and in combination with simvastatin on serum lipid profile in hyperlipidemic albino rats","volume":"27","author":"Kausar","year":"2011","journal-title":"Biomedica"},{"issue":"10","key":"10.1016\/j.biopha.2021.111494_bib48","doi-asserted-by":"crossref","first-page":"2866","DOI":"10.1093\/humrep\/dei120","article-title":"Simvastatin has deleterious effects on human first trimester placental explants","volume":"20","author":"Kenis","year":"2005","journal-title":"Hum. Reprod."},{"issue":"8","key":"10.1016\/j.biopha.2021.111494_bib49","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/j.metabol.2008.01.037","article-title":"Combination of simvastatin with berberine improves the lipid-lowering efficacy","volume":"57","author":"Kong","year":"2008","journal-title":"Metab. Clin. Exp."},{"issue":"6","key":"10.1016\/j.biopha.2021.111494_bib50","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.2337\/diabetes.51.6.1708","article-title":"Differential effects of fenofibrate or simvastatin treatment of rats on hepatic microsomal overt and latent diacylglycerol acyltransferase activities","volume":"51","author":"Waterman","year":"2002","journal-title":"Diabetes"},{"issue":"10","key":"10.1016\/j.biopha.2021.111494_bib51","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.dld.2006.04.013","article-title":"Atorvastatin associated liver disease","volume":"38","author":"Clarke","year":"2006","journal-title":"Dig. Liver Dis."},{"key":"10.1016\/j.biopha.2021.111494_bib52","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.redox.2016.05.007","article-title":"Simvastatin and oxidative stress in humans: a randomized, double-blinded, placebo-controlled clinical trial","volume":"9","author":"Rasmussen","year":"2016","journal-title":"Redox Biol."},{"issue":"2","key":"10.1016\/j.biopha.2021.111494_bib53","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.bmcl.2007.11.107","article-title":"Inhibition of dipeptidyl peptidase-IV (DPP-IV) by atorvastatin","volume":"18","author":"Taldone","year":"2008","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"3","key":"10.1016\/j.biopha.2021.111494_bib54","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1016\/j.bbrc.2005.10.108","article-title":"Simvastatin induces impairment in skeletal muscle while heart is protected","volume":"338","author":"Sirvent","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"5","key":"10.1016\/j.biopha.2021.111494_bib55","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1097\/00005072-199309000-00012","article-title":"Experimental lovastatin myopathy","volume":"52","author":"Waclawik","year":"1993","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"5","key":"10.1016\/j.biopha.2021.111494_bib56","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1002\/mus.20291","article-title":"Molecular clues into the pathogenesis of statin\u2010mediated muscle toxicity","volume":"31","author":"Baker","year":"2005","journal-title":"Muscle Nerve"},{"issue":"3","key":"10.1016\/j.biopha.2021.111494_bib57","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/j.bbrc.2005.02.070","article-title":"Simvastatin triggers mitochondria-induced Ca 2+ signaling alteration in skeletal muscle","volume":"329","author":"Sirvent","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"3","key":"10.1016\/j.biopha.2021.111494_bib58","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.taap.2005.03.004","article-title":"Statins and PPAR\u03b1 agonists induce myotoxicity in differentiated rat skeletal muscle cultures but do not exhibit synergy with co-treatment","volume":"208","author":"Johnson","year":"2005","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"6","key":"10.1016\/j.biopha.2021.111494_bib59","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.amjmed.2003.10.033","article-title":"Current overview of statin-induced myopathy","volume":"116","author":"Rosenson","year":"2004","journal-title":"Am. J. Med."},{"issue":"9412","key":"10.1016\/j.biopha.2021.111494_bib60","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/S0140-6736(04)15739-5","article-title":"Selenoprotein synthesis and side-effects of statins","volume":"363","author":"Moosmann","year":"2004","journal-title":"Lancet"},{"issue":"13","key":"10.1016\/j.biopha.2021.111494_bib61","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1001\/jama.289.13.1681","article-title":"Statin associated myopathy","volume":"289","author":"hompson","year":"2003","journal-title":"J. Am. Med. Assoc."},{"issue":"1","key":"10.1016\/j.biopha.2021.111494_bib62","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1006\/taap.1997.8131","article-title":"Inhibition of cholesterol synthesis by squalene synthase inhibitors does not induce myotoxicityin vitro","volume":"145","author":"Flint","year":"1997","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"2A","key":"10.1016\/j.biopha.2021.111494_bib63","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1590\/S0004-282X2004000200013","article-title":"Statin and fibrate associed myopathy: study of eight patients","volume":"62","author":"Carvalho","year":"2004","journal-title":"Arq. Neuro-Psiquiatr."},{"issue":"2","key":"10.1016\/j.biopha.2021.111494_bib64","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1159\/000020651","article-title":"Pathogenesis of renal failure in rhabdomyolysis: the role of myoglobin","volume":"8","author":"Holt","year":"2000","journal-title":"Nephron Exp. Nephrol."},{"issue":"6","key":"10.1016\/j.biopha.2021.111494_bib65","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1227\/01.NEU.0000360130.52812.1D","article-title":"Effect of simvastatin on glioma cell proliferation, migration, and apoptosis","volume":"65","author":"Wu","year":"2009","journal-title":"Neurosurgery"},{"key":"10.1016\/j.biopha.2021.111494_bib66","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.ijpharm.2019.02.002","article-title":"Simvastatin-loaded solid lipid nanoparticles for enhanced anti-hyperlipidemic activity in hyperlipidemia animal model","volume":"560","author":"Rizvi","year":"2019","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.biopha.2021.111494_bib67","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111354","article-title":"Solid-lipid nanoparticle formulation improves antiseizure action of cryptolepine","volume":"137","author":"Mante","year":"2021","journal-title":"Biomed. Pharmacother."},{"issue":"10","key":"10.1016\/j.biopha.2021.111494_bib68","doi-asserted-by":"crossref","first-page":"691","DOI":"10.4155\/tde-2016-0038","article-title":"Biological voyage of solid lipid nanoparticles: a proficient carrier in nanomedicine","volume":"7","author":"Ali","year":"2016","journal-title":"Ther. Deliv."},{"key":"10.1016\/j.biopha.2021.111494_bib69","doi-asserted-by":"crossref","unstructured":"R. Elkatary, K. Abdelrahman, A. Hassanin, A.I. Elmasry, A.E. Karef, Comparative study between effect of simvastatin (5 mg\/kg) and simvastatin (50 mg\/kg) in an early treatment of experimentally induced colitis in mice, 2015.","DOI":"10.9734\/BJMMR\/2015\/18314"},{"key":"10.1016\/j.biopha.2021.111494_bib70","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.msec.2016.05.119","article-title":"Solid lipid nanoparticles as attractive drug vehicles: composition, properties and therapeutic strategies","volume":"68","author":"Geszke-Moritz","year":"2016","journal-title":"Mater. Sci. Eng.: C"},{"issue":"3","key":"10.1016\/j.biopha.2021.111494_bib71","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0119784","article-title":"High-fat diet-induced adiposity, adipose inflammation, hepatic steatosis and hyperinsulinemia in outbred CD-1 mice","volume":"10","author":"Gao","year":"2015","journal-title":"PloS One"},{"key":"10.1016\/j.biopha.2021.111494_bib72","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2019.172616","article-title":"Mechanisms of simvastatin myotoxicity: the role of autophagy flux inhibition","volume":"862","author":"Emami","year":"2019","journal-title":"Eur. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.biopha.2021.111494_bib73","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.ijcard.2011.07.048","article-title":"Managing the underestimated risk of statin-associated myopathy","volume":"159","author":"Rallidis","year":"2012","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.biopha.2021.111494_bib74","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.jddst.2019.02.026","article-title":"Development, in-vitro and in-vivo evaluation of ezetimibe-loaded solid lipid nanoparticles and their comparison with marketed product","volume":"51","author":"ud Din","year":"2019","journal-title":"J. Drug Deliv. Sci. Technol."},{"issue":"1","key":"10.1016\/j.biopha.2021.111494_bib75","first-page":"216","article-title":"Histological study on the effect of simavastatin on the skeletal muscle fibers in albino rat and the possible protective effect of coenzyme Q 10. Egypt","volume":"31","author":"Hassan","year":"2009","journal-title":"J. Histol."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332221002791?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332221002791?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T12:41:19Z","timestamp":1760100079000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332221002791"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":75,"alternative-id":["S0753332221002791"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2021.111494","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic advancement of simvastatin-loaded solid lipid nanoparticles (SV-SLNs) in treatment of hyperlipidemia and attenuating hepatotoxicity, myopathy and apoptosis: Comprehensive study","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2021.111494","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"111494"}}